Moxonidine in Patients Undergoing Vascular Surgery

NCT00244504 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

141

Enrollment

OTHER

Sponsor class

Stopped Study was stopped after pre-definied interim analysis because of no effects

Conditions

Cardiac Disease
Vascular Surgery

Interventions

DRUG: moxonidine

Sponsor

University Hospital, Basel, Switzerland